Tirzepatide Microdose
US$ 27.42
futurhealth glp 1 Apple links its fitness app to FuturHealth's GLP-1 weight-loss platform The future of GLP-1 drugs
Description
Advantage: Eli Lilly has the advantage of possessing a next-generation drug (tirzepatide) that has demonstrated impressive results, particularly in the obesity space
doi: 10.1007/S11154-023-09807-3 13 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFENauckMAet al
DURATION-2 Study Group
The lack of effect of ghrelin on GIP secretion shown here and reported by Tong et al
So, while low natural levels might appear to have little effect at first glance, a slight increase in levels by dietary manipulation of GLP-1 secretion could be sufficient to have clinical relevance
